glp-1/gin medications GLP-1 Weight Loss Options Non GMOVegan World Health Organization issues first-ever

Both oral and injectable GLP-1 treatments may cause nausea, vomiting, constipation, diarrhea, abdominal discomfort, and reduced food tolerance

Safety, tolerability, and efficacy of NLY01 in early untreated Parkinsons disease: a randomised, double-blind, placebo-controlled trial

2024;137(8):761-9.e1

An analytical study based on post-marketing approval pharmacovigilance data

On the other hand, cardiovascular tissues react to GLP-1 via activated survival pathways, indicating possible protective benefits

When deciding between shots and pills, your choice will ultimately depend on your medical eligibility, lifestyle, and preferences